Caplin Point Laboratories Ltd. (CAPLIPOINT) closed at ₹2,084.60 on 19 Nov 2026, down 0.03 % on the day. Over the past year it is up 7.1 %; it stands 30.3 % below its 52-week high; it trades below its 200-day average. Its P/E is 23.0 on the last four quarters' profit. In Q2 FY27 (Jul-Sep 2026), profit grew 15.3 % and revenue grew 17.9 % from a year earlier, as the company reported. It is part of the NIFTY 500, in the Healthcare sector.
Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance
The line uses prices adjusted for splits, bonuses and similar events.
Results in short
Q2 FY27 (Jul-Sep 2026), as the company reported it.
Caplin Point Laboratories Ltd. is part of the NIFTY 500. Figures are consolidated, from the company's results filed with NSE. Quality checks and outlook cover NIFTY 50 companies only, for now.